InsidersTradesSigma
Browse the complete record of transactions filed by Poirier Michael S., Chairman & CEO. Officer active across 1 company, notably Qualigen Therapeutics, Inc.. Aggregated, 1 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €16k. Activity tracked since 22 June 2022. The latest transaction was disclosed on 22 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Michael S. Poirier is the Chairman & CEO of Qualigen Therapeutics, Inc. He is responsible for the strategic direction of the company and the implementation of its vision. His experience in the biopharmaceutical sector is essential for guiding the organization towards sustainable growth.